Apyx Medical Inc(APYX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

APYX Apyx Medical Inc

Trading 06-10 10:10:52 EDT

4.79

-0.07

-1.43%

High4.93	Low4.73	Vol12.33K
Open4.88	D1 Closing4.86	Amplitude4.12%
Mkt Cap200.38M	Tradable Cap139.32M	Total Shares41.83M
T/O59.94K	T/O Rate0.04%	Tradable Shares29.08M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"APYX","market":"US","secType":"STK","nameCN":"Apyx Medical Inc","latestPrice":4.7904,"timestamp":1781100580653,"preClose":4.86,"halted":0,"volume":12325,"delay":0,"changeRate":-0.014320987654321054,"floatShares":29084100,"shares":41829226,"eps":-0.219101,"marketStatus":"Trading","change":-0.0696,"latestTime":"06-10 10:10:52 EDT","open":4.88,"high":4.93,"low":4.73,"amount":59944.609500000006,"amplitude":0.041152,"askPrice":4.84,"askSize":200,"bidPrice":4.79,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.219101,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1781121600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":4.86,"preHourTrading":{"tag":"盘前","latestPrice":4.93,"preClose":4.86,"latestTime":"09:19 EDT","volume":1078,"amount":5296.239872,"timestamp":1781097555895,"change":0.07,"changeRate":0.014403,"amplitude":0.026749},"postHourTrading":{"tag":"盘后","latestPrice":4.86,"preClose":4.86,"latestTime":"18:07 EDT","volume":1307,"amount":6365.892,"timestamp":1781042838009,"change":0,"changeRate":0,"amplitude":0.020576},"volumeRatio":0.422648,"impliedVol":1.3918,"impliedVolPercentile":0.4263},"requestUrl":"/m/hq/s/APYX/tweets","defaultTab":"tweets","newsList":[{"id":"2637333781","title":"Apyx Medical study shows 81.8% cellulite improvement using Avéli-Renuvion combo","url":"https://stock-news.laohu8.com/highlight/detail?id=2637333781","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637333781?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:03","pubTimestamp":1779365012,"startTime":"0","endTime":"0","summary":"Apyx Medical reported published clinical data on May 21, 2026 in Aesthetic Surgery Journal Open Forum from a prospective, investigator-initiated study evaluating a combined use of Avéli subcision followed by the company’s Renuvion device for cellulite and skin laxity.The results have already been presented in the publication, covering outcomes through 180 days in 22 patients treated in a single session.The study showed visible, sustained improvement in cellulite appearance over time, with imaging indicating meaningful reductions in dimpling in some cases.Findings also supported improved skin quality consistent with ongoing tissue remodeling, based on laboratory analysis in a subset of patients.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDLlWT75:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","IE00BKPKM429.USD","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BGHQF748.EUR","SG9999014005.SGD","IE00B64PRP62.GBP","BK4588","BK4112","LU2095319765.USD","LU0314104364.USD","APYX","IE00B3QW5Z07.USD","SG9999014021.USD","NDAQ","BK4585","LU2210150020.SGD","SG9999014039.USD","LU2210149790.SGD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635712055","title":"Apyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with Liposuction","url":"https://stock-news.laohu8.com/highlight/detail?id=2635712055","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635712055?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:00","pubTimestamp":1778760000,"startTime":"0","endTime":"0","summary":"Analysis showed that liposuction followed by helium plasma RF was associated with higher patient-reported satisfaction with abdominal appearance, lower abdominoplasty and revision rates, and comparabl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/14/3294885/0/en/Apyx-Medical-Corporation-Announces-Retrospective-Clinical-Publication-Evaluating-Clinical-Benefit-of-Renuvion-Used-in-Combination-with-Liposuction.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","APYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634016238","title":"Apyx Medical Shares Rise After FDA Expands Clearance for AYON Liposuction Feature","url":"https://stock-news.laohu8.com/highlight/detail?id=2634016238","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634016238?lang=en_us&edition=fundamental","pubTime":"2026-05-11 23:21","pubTimestamp":1778512860,"startTime":"0","endTime":"0","summary":"Apyx Medical shares rose after the company received an expanded U.S. regulatory clearing for its aesthetic device to include an advanced form of liposuction.Shares rose 7.9% to $3.96 in Monday morning trading. The stock is up almost 40% in the past five days.The company, which makes surgical aesthetic products, was granted expanded clearance for its AYON Body Contouring System from the Food and Drug Administration. The clearance allows the device to be used for power liposuction, a motor-assisted form of the procedure that uses a rapidly moving tube to make fat removal faster and more efficient.Chief Executive Charlie Goodwin said that it plans to kick off a limited commercial launch of the power liposuction function to help early adopters to refine training, utilization and overall customer experience before fully scaling up.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","APYX","BK4082","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634812262","title":"BRIEF-Apyx Medical Corporation Receives Expanded FDA 510(K) Clearance Adding Power Liposuction Capability To AYON Body Contouring System™","url":"https://stock-news.laohu8.com/highlight/detail?id=2634812262","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634812262?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:52","pubTimestamp":1778503928,"startTime":"0","endTime":"0","summary":"BRIEF-Apyx Medical Corporation Receives Expanded FDA 510(K) Clearance Adding Power Liposuction Capability To AYON Body Contouring SystemMay 11 (Reuters) - Apyx Medical Inc APYX.O:APYX MEDICAL CORPORAT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nTUA2Q3T2D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APYX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634286169","title":"Apyx Medical wins FDA 510(k) clearance adding power liposuction to AYON system","url":"https://stock-news.laohu8.com/highlight/detail?id=2634286169","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634286169?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:01","pubTimestamp":1778500899,"startTime":"0","endTime":"0","summary":"Apyx Medical won expanded FDA 510 clearance for AYON Body Contouring System to add power liposuction capability.Clearance allows use of a reciprocating cannula for fat removal, targeting lower surgeon effort and shorter operating room time.Limited commercial launch planned ahead of broader rollout.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL1xLVQk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BK4082","LU2210150020.SGD","IE00B64PRP62.GBP","SG9999014013.SGD","IE00BGHQF748.EUR","BK4588","SG9999014005.SGD","IE00BKPKM429.USD","LU0314104364.USD","IE00BN0W2T93.GBP","SG9999014039.USD","BK4112","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","BK4585","LU2210149790.SGD","NDAQ","SG9999014021.USD","APYX","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634613286","title":"Apyx Medical Inc - Receives Expanded FDA 510(K) Clearance for Ayon Body Contouring System","url":"https://stock-news.laohu8.com/highlight/detail?id=2634613286","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634613286?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:00","pubTimestamp":1778500801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nTUA2Q3T2D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","APYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634028669","title":"Apyx Medical Inc - to Begin Limited Commercial Launch of Power Liposuction Function","url":"https://stock-news.laohu8.com/highlight/detail?id=2634028669","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634028669?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:00","pubTimestamp":1778500801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nTUA2Q3T2D:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","APYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633451391","title":"Apyx Medical Q1 revenue beats estimates, outlook raised","url":"https://stock-news.laohu8.com/highlight/detail?id=2633451391","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633451391?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:08","pubTimestamp":1778152119,"startTime":"0","endTime":"0","summary":"Apyx Medical Q1 revenue beats estimates, outlook raisedOverviewUS surgical aesthetics firm's Q1 revenue rose 32% yr/yr, beating analyst expectationsQ1 adjusted EBITDA loss narrowed and beat analyst ex","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL1N41K0L8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","APYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633432261","title":"Apyx Medical Q1 EPS $(0.05) Beats $(0.10) Estimate, Sales $12.490M Beat $10.868M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633432261","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633432261?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:01","pubTimestamp":1778151692,"startTime":"0","endTime":"0","summary":"Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.10) by 50 percent. This is a 50 percent increase over losses of $(0.10) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52359467/apyx-medical-q1-eps-0-05-beats-0-10-estimate-sales-12-490m-beat-10-868m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APYX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633432201","title":"BRIEF-Apyx Medical Corporation Q1 EPS USD -0.05","url":"https://stock-news.laohu8.com/highlight/detail?id=2633432201","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633432201?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:00","pubTimestamp":1778151656,"startTime":"0","endTime":"0","summary":"May 07  - Apyx Medical Corporation Q1 sales USD 12.49 million vs. IBES estimate USD 10.9 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLX2D69F0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","APYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633961145","title":"Apyx Medical Corporation Outlook FY Revenue USD 59-60 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633961145","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633961145?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:00","pubTimestamp":1778151612,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLX2D69F0:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APYX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633714518","title":"Apyx Medical Inc: Continues to Expect Operating Expenses of Less Than $45.0 Mln for Year Ended December 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633714518","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633714518?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:00","pubTimestamp":1778151612,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLX2D69F0:9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APYX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633143900","title":"Apyx Medical Corporation Q1 Pretax Profit USD -2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633143900","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633143900?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:00","pubTimestamp":1778151612,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLX2D69F0:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","APYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633143420","title":"Apyx Medical Corporation Q1 Adjusted Ebitda USD -326 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2633143420","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633143420?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:00","pubTimestamp":1778151612,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLX2D69F0:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APYX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633431211","title":"Apyx Medical Corporation Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633431211","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633431211?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:00","pubTimestamp":1778151609,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nTUA3KXHW1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APYX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633117886","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2633117886","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633117886?lang=en_us&edition=fundamental","pubTime":"2026-05-07 18:00","pubTimestamp":1778148000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Ares Comm. RE                                   1Q       .07    6:00 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMPX","AFCG","ARWR","ASPN","ANAB","BBDC","ASC","BKV","AMTX","AORT","ACRE","AKAM","AHR","BBIO","AKBA","AURA","ACHR","AVPT","ABSI","ALRM","ABX","AMN","AMLX","ARGX","ARCT","ALGM","AGO","ARHS","ABNB","ASTH","ARLO","ALTG","ASMB","AAOI","ACMR","ACLS","AMPH","ARTV","ATHM","ARW","AAON","ALT","AFRM","ASND","APPN","ATLC","APYX","AVNT","ACIW","DDOG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633194586","title":"Apyx Medical Inc  expected to post a loss of 11 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633194586","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633194586?lang=en_us&edition=fundamental","pubTime":"2026-05-05 21:06","pubTimestamp":1777986365,"startTime":"0","endTime":"0","summary":"Apyx Medical Inc  expected to post a loss of11cents a share - Earnings Preview Apyx Medical Inc APYX.OQ APYX.O is expected to  show a rise in quarterly revenue when it reports  results on May 7 for th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nL8N41I1PQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APYX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629836007","title":"Apyx Medical to report first-quarter results, host earnings call","url":"https://stock-news.laohu8.com/highlight/detail?id=2629836007","media":"Reuters","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629836007?lang=en_us&edition=fundamental","pubTime":"2026-04-23 20:01","pubTimestamp":1776945660,"startTime":"0","endTime":"0","summary":"Apyx Medical to release fiscal 2026 first-quarter financial results before market open May 7, 2026.Management to host earnings conference call at 8:00 a.m. ET on May 7, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL2CcSzk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK4112","APYX","SG9999014013.SGD","BK4082","IE00BN0W2T93.GBP","SG9999014021.USD","BK4585","SG9999014005.SGD","IE00BN0W2V16.EUR","NDAQ","LU2210150020.SGD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","LU0314104364.USD","IE00B3QW5Z07.USD","SG9999014039.USD","LU2210149790.SGD","BK4588","LU2095319765.USD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627422607","title":"Apyx Medical (APYX) Receives a Buy from Roth MKM","url":"https://stock-news.laohu8.com/highlight/detail?id=2627422607","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627422607?lang=en_us&edition=fundamental","pubTime":"2026-04-15 05:16","pubTimestamp":1776201371,"startTime":"0","endTime":"0","summary":"In a report released today, Kyle Bauser from Roth MKM reiterated a Buy rating on Apyx Medical, with a price target of $6.00. Bauser covers the Heal...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/apyx-medical-apyx-receives-a-buy-from-roth-mkm-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/apyx-medical-apyx-receives-a-buy-from-roth-mkm-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APYX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618920487","title":"Apyx Medical Shares Rise After BTIG Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2618920487","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618920487?lang=en_us&edition=fundamental","pubTime":"2026-03-12 02:49","pubTimestamp":1773254982,"startTime":"0","endTime":"0","summary":"Apyx Medical (APYX) shares rose 14.8% in Wednesday trading after BTIG upgraded the stock to buy from neutral with a price target of $6.Trading volume stood at nearly 501,000 shares, compared with a daily average of about 108,000.Price: 3.96, Change: +0.51, Percent Change: +14.78","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["APYX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.apyxmedical.com","stockEarnings":[{"period":"1week","weight":0.2623},{"period":"1month","weight":0.3243},{"period":"3month","weight":0.2366},{"period":"6month","weight":0.218},{"period":"1year","weight":1.8092},{"period":"ytd","weight":0.3886}],"compareEarnings":[{"period":"1week","weight":-0.0296},{"period":"1month","weight":-0.0008},{"period":"3month","weight":0.0898},{"period":"6month","weight":0.0695},{"period":"1year","weight":0.2291},{"period":"ytd","weight":0.0808}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and laparoscopic surgical procedures. The company's Helium Plasma Technology products are marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It also offers hand pieces for open and laparoscopic procedures, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.","yearOnYearQuotes":[{"month":1,"riseRate":0.53125,"avgChangeRate":0.052775},{"month":2,"riseRate":0.4375,"avgChangeRate":0.02708},{"month":3,"riseRate":0.25,"avgChangeRate":-0.087392},{"month":4,"riseRate":0.65625,"avgChangeRate":0.033988},{"month":5,"riseRate":0.515152,"avgChangeRate":0.071476},{"month":6,"riseRate":0.484848,"avgChangeRate":0.041036},{"month":7,"riseRate":0.625,"avgChangeRate":0.030241},{"month":8,"riseRate":0.5,"avgChangeRate":0.028214},{"month":9,"riseRate":0.4375,"avgChangeRate":0.020348},{"month":10,"riseRate":0.4375,"avgChangeRate":0.012238},{"month":11,"riseRate":0.46875,"avgChangeRate":0.044253},{"month":12,"riseRate":0.387097,"avgChangeRate":-0.006745}],"exchange":"NASDAQ","name":"Apyx Medical Inc","nameEN":"Apyx Medical Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Apyx Medical Inc(APYX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Apyx Medical Inc(APYX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Apyx Medical Inc,APYX,Apyx Medical Inc股票,Apyx Medical Inc股票老虎,Apyx Medical Inc股票老虎国际,Apyx Medical Inc行情,Apyx Medical Inc股票行情,Apyx Medical Inc股价,Apyx Medical Inc股市,Apyx Medical Inc股票价格,Apyx Medical Inc股票交易,Apyx Medical Inc股票购买,Apyx Medical Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Apyx Medical Inc(APYX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Apyx Medical Inc(APYX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction